Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work?

First published on

PharmaVoice

Eli Lilly and Pfizer have both recently launched direct-to-consumer platforms allowing patients to bypass an in-person doctor visit or brick-and-mortar pharmacy. Their decisions suggest large pharmaceutical companies are exploring new ways to reach patients and could indicate…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks